Eli Lilly slumps after cutting profit outlook despite rising weight-loss drug profits
Eli LillyLYLYIt posted better-than-expected third-quarter earnings on Thursday thanks to continued growth in sales of its anti-obesity drug Mounjaro, which ...
Tag: Drug
Pharma and PBM argue over rising drug costs amid public scrutiny
Nadzeya Haroshka Leading pharmaceutical lobbying group PhRMA and drug brokers known as pharmacy benefit managers (PBMs) have resumed their long-running ...
New deep learning research identifies antimalarial drug as potential treatment for osteoporosis
The problem of osteoporosis, a disease characterized by excessive bone loss and an increased risk of fractures, has long affected ...
Stocks extend slide, Chevron mega deal, Apple plunges, two-year auction underway, Roivant drug sale: 5 things to know
Five things you need to know before the market opens on Monday, October 23:1. -- stock market Today: stocks Fall, ...
Aid agency urges Johnson & Johnson to improve access to TB drug By Reuters
© Reuters. FILE PHOTO: The Johnson & Johnson logo is seen at a company office in Brussels in Diegem, Belgium, ...
Kinnate slashes workforce by 70%, shelves three drug programs (KNTE)
WendellandCarolyn/iStock via Getty Images Kinnate Biopharma (NASDAQ:KNTE) said late Monday that it was slashing its workforce by 70% as part ...
Eli Lilly, Novo to lead weight loss drug market: JPMorgan
Fotolia/iStock via Getty Images JPMorgan recently raised its projections for weight loss drugs, expecting the drug category known as GLP-1 ...
Metformin could affect sales of Pfizer’s COVID drug Paxlovid
Scott Olson/Getty Images News With Pfizer saying in January that it expects a big decline in revenue from its COVID-19 ...
US FDA approves Pharming’s immune disorders drug By Reuters
© Reuters. FILE PHOTO: Signage outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, ...
Dermatology drug developer Azitra increases size of proposed initial public offering to $20 million (AZTR)
andrei tolkachev Dermatology drug developer Azitra (AZTR) has slightly increased its initial public offering proposal to $20 million. Azitra said ...
Recommended.
